Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Zentalis Pharmaceuticals Announces FDA Has Lifted Partial Clinical Hold on Azenosertib Studies
-
Can-Fite: Pancreatic Carcinoma Phase IIa Clinical Study with Namodenoson Received Regulatory Authorization from the Israeli Ministry of Health
-
Pivotal ApproaCH Trial of TransCon™ CNP (Navepegritide) Achieved Primary Objective, Demonstrated AGV Superior to Placebo
-
BeyondSpring Presents Final Data Analysis of DUBLIN-3 Phase 3 Study in 2L/3L EGFR Wild-type NSCLC at ESMO Congress 2024
-
Nayax Partners with Adyen to Globally Expand Electric Vehicle Charging and Automated Self-Service Payments Infrastructure
-
Chicago Atlantic Real Estate Finance Declares Common Stock Dividend of $0.47 for the Third Quarter of 2024
-
BeyondSpring Presents Efficacy/Safety Results from a Phase 2 Study of Pembrolizumab plus Plinabulin/Docetaxel in Metastatic NSCLC after Progressing on First-Line Immune Checkpoint Inhibitors at ESMO C
-
InspireMD Announces Submission of Premarket Approval Application to FDA Seeking U.S. Regulatory Approval of the CGuard™ Prime Carotid Stent System
-
Voyager Advances Collaboration with Neurocrine; Third Gene Therapy Development Candidate Selected
-
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Mercury Introduces New Small Form Factor Digital Signal Processing Module Powered by Altera Agilex FPGAs
-
Bio-Path Holdings Announces Publication in Biomedicines
-
ASDS Experts Share Procedural Dermatology Techniques at Unique Hands-on Course With Innovative 3D Technology
-
General Presidents’ Maintenance Committee for Canada & National Maintenance Council for Canada Opens Bursary Applications
-
Tonix Pharmaceuticals Announces That its Single Dose Mpox Vaccine Candidate TNX-801 Aligns with WHO’s Newly Issued Preferred Target Product Profile for Mpox Vaccines in Global Health Emergency
-
Lantronix Announces CFO Departure and Transition Plan
-
Crypto Plus offers influential sources, enhancing the capabilities of the crypto community.
-
Can-Fite: Pancreatic Carcinoma Phase IIa Clinical Study with Namodenoson Received Regulatory Authorization from the Israeli Ministry of Health
-
Eisbach Bio Announces First Patient Dosed in Phase 1/2 Trial for EIS-12656, a First-In-Class Allosteric Inhibitor of ALC1 in Refractory Advanced Solid Tumors
-
Critical Metals Corp to Participate in Fastmarkets European Battery Raw Materials Conference 2024
-
Abata Therapeutics Appoints Joanne Beck, Ph.D., as Chief Technical Officer
-
Dorman® OE FIX™, turbocharger system components and in-demand repair solutions highlight September new product releases
-
Kratos Awarded Multi-Million Dollar Ground System Contract by Thaicom to Enable the Full Power of its New Software-Defined Satellite
-
LXP Industrial Trust Announces Quarterly Common Share Dividend
-
Silvaco Announces Expected Addition to Three US Russell Indexes
-
Ashland accelerates application of super wetting technology, commercializes superior wetting agent for corn, soy, wheat, watermelon, other produce and florals
-
Nearly 2 in 5 Americans Owe More on Credit Cards Than They Have Saved for Retirement
-
Cullinan Therapeutics Announces Submission of Investigational New Drug Application to U.S. Food and Drug Administration for CLN-978 to Treat Systemic Lupus Erythematosus
-
Capstreet-backed SmartSights Acquires Sage Clarity
-
Green Thumb Industries Announces $50 Million Share Repurchase Program
-
PDS Biotech Announces Updated Results from VERSATILE-002 Phase 2 Clinical Trial Presented at ESMO 2024
-
Passage Bio to Present Positive Interim Data from Cohort 1 Patients with FTD-GRN in upliFT-D Study at 14th International Conference on Frontotemporal Dementias (ISFTD2024)
-
Stingray Brings Karaoke Fun to NIO Vehicles Across Europe
-
General Presidents’ Maintenance Committee for Canada & National Maintenance Council for Canada Opens Bursary Applications
-
VEON Delegation Attends 2024 YES Annual Meeting, Discusses Investment and Continued Commitment to Serving Ukraine
-
Sampo plc: new Sampo A shares issued to Topdanmark shareholders in connection with the exchange offer registered with the Finnish Trade Register
-
VEON Delegation Attends 2024 YES Annual Meeting, Discusses Investment and Continued Commitment to Serving Ukraine
-
Evaxion reports convincing one-year data from phase 2 trial on AI-designed personalized cancer vaccine EVX-01
-
Gauzy to Unveil Next Generation AI-Powered Advanced Driver Assistance System (ADAS) for Commercial Trucks at IAA TRANSPORTATION 2024
-
Wabash Honored as One of America's Most Admired Workplaces 2025 by Newsweek
-
SoFi Announces Monthly Distributions on $THTA (9.00%)
-
D.O.G.E Hits $13M MarketCap Shortly After Launch, The New Memecoin Sensation Set to Become the Dogecoin of a New Era?
-
Tidal Financial Group Unveils “The ETF Masters” Brand, Cementing Market Leadership Amid Record Growth
-
Reliance, Inc. Announces Amended and Restated $1.5 Billion Credit Facility
-
ANI Pharmaceuticals Initiates Closing of Acquisition of Alimera Sciences
-
WISDOMTREE MULTI ASSET ISSUER PUBLIC LIMITED COMPANY (the “ISSUER”) (a public company incorporated with limited liability in Ireland)
-
LIS Technologies Inc. Appoints 38-Year Security Licensing Veteran Keith Everly as its Head Security and IP Management
-
ThreeD Capital Inc. Announces Its Intention To Effect A Normal Course Issuer Bid
-
Cybrexa Therapeutics Announces Positive Final Data at ESMO 2024 from Phase 1 Study of Peptide Drug Conjugate CBX-12 in Advanced Solid Tumors
-
USI’s 11th Annual Nationwide Gives Back Community Investment Campaign Supports Local Communities Through More Than 24,000 Hours of Volunteerism
